Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic Concerto

This article was originally published in The Gray Sheet

Executive Summary

Firm announces the first patient implants of its Concerto AT CRT-D device with atrial therapies Feb. 1. The prospective, non-randomized trial will include 425 patients indicated for cardiac resynchronization therapy and implantable cardioverter defibrillators at 50 sites in Europe, Japan and the U.S. Medtronic's Concerto CRT-D and its Virtuoso ICD will be the firm's first devices to incorporate Conexus telemetry for automatic, wireless transmission of implanted device data to the firm's CareLink internet-based monitoring system...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT023189

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel